Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1396029
PUBLISHER: GlobalData | PRODUCT CODE: 1396029
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Abstract
GlobalData's Medical Devices sector report, "Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Colorectal Cancer Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Colorectal Cancer Screening Tests includes Guaiac Fecal Occult Blood Test (gFOBT) Kits, Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits, Fecal DNA Test Kits and Other Colorectal Cancer Screening Tests.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Colorectal Cancer Screening Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Colorectal Cancer Screening Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Colorectal Cancer Screening Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Colorectal Cancer Screening Tests Overview
3 Products under Development
- 3.1 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
- 3.2 Colorectal Cancer Screening Tests - Pipeline Products by Segment
- 3.3 Colorectal Cancer Screening Tests - Pipeline Products by Territory
- 3.4 Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
- 3.5 Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
- 3.6 Colorectal Cancer Screening Tests - Ongoing Clinical Trials
4 Colorectal Cancer Screening Tests - Pipeline Products under Development by Companies
- 4.1 Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
- 4.2 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
5 Colorectal Cancer Screening Tests Companies and Product Overview
- 5.1 Acuamark Diagnostics Inc Company Overview
- 5.1.1 Acuamark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Anixa Diagnostics Corporation Company Overview
- 5.2.1 Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 Arbele Corp Company Overview
- 5.3.1 Arbele Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 Augusta University Company Overview
- 5.4.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 Bar Harbor BioTechnology Inc (Inactive) Company Overview
- 5.5.1 Bar Harbor BioTechnology Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 Beacon Biomedical Inc Company Overview
- 5.6.1 Beacon Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 Beckman Research Institute Of The City Of Hope Company Overview
- 5.7.1 Beckman Research Institute Of The City Of Hope Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 Beijing Youxun Medical Laboratory Co Ltd Company Overview
- 5.8.1 Beijing Youxun Medical Laboratory Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 BGI Genomics Co Ltd Company Overview
- 5.9.1 BGI Genomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Biocartis Group NV Company Overview
- 5.10.1 Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Biome Diagnostics GmbH Company Overview
- 5.11.1 Biome Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 Castle Biosciences Inc Company Overview
- 5.12.1 Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 CellMax Life Inc Company Overview
- 5.13.1 CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 Celtic Medical BV Company Overview
- 5.14.1 Celtic Medical BV Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 CRC Bioscreen Company Overview
- 5.15.1 CRC Bioscreen Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 Creative Biosciences (Guangzhou) Co Ltd Company Overview
- 5.16.1 Creative Biosciences (Guangzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Curo Biosciences Pvt Ltd Company Overview
- 5.17.1 Curo Biosciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 Diagen Company Overview
- 5.18.1 Diagen Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 DiagNodus Ltd Company Overview
- 5.19.1 DiagNodus Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 EHang (Suzhou) Biomedical Co Ltd Company Overview
- 5.20.1 EHang (Suzhou) Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Epigenomics Inc Company Overview
- 5.21.1 Epigenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.22 Exact Sciences Corp Company Overview
- 5.22.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.23 Foundation Medicine Inc Company Overview
- 5.23.1 Foundation Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.24 G Medical Health and Wellness Company Overview
- 5.24.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview
- 5.25 Geneoscopy LLC Company Overview
- 5.25.1 Geneoscopy LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.26 Genetic Technologies Ltd Company Overview
- 5.26.1 Genetic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.27 Genetron Health (Beijing) Co Ltd Company Overview
- 5.27.1 Genetron Health (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.28 Genoptix Inc (Inactive) Company Overview
- 5.28.1 Genoptix Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.29 Guardant Health Inc Company Overview
- 5.29.1 Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.30 Human Metabolome Technologies Inc Company Overview
- 5.30.1 Human Metabolome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.31 iCellate Medical AB Company Overview
- 5.31.1 iCellate Medical AB Pipeline Products & Ongoing Clinical Trials Overview
- 5.32 Interpace Biosciences Inc Company Overview
- 5.32.1 Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.33 JL Medi Labs Co Ltd Company Overview
- 5.33.1 JL Medi Labs Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.34 Mainz Biomed NV Company Overview
- 5.34.1 Mainz Biomed NV Pipeline Products & Ongoing Clinical Trials Overview
- 5.35 mBioSys Pvt Ltd Company Overview
- 5.35.1 mBioSys Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.36 Neuome Peptides Pte Ltd Company Overview
- 5.36.1 Neuome Peptides Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.37 Oncodiag Company Overview
- 5.37.1 Oncodiag Pipeline Products & Ongoing Clinical Trials Overview
- 5.38 Oncomark Ltd Company Overview
- 5.38.1 Oncomark Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.39 Ourotech Ltd Company Overview
- 5.39.1 Ourotech Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.40 Prenetics Ltd Company Overview
- 5.40.1 Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.41 Preora Healthcare Inc Company Overview
- 5.41.1 Preora Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.42 QuantuMDx Group Ltd Company Overview
- 5.42.1 QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.43 Rarity Bioscience AB Company Overview
- 5.43.1 Rarity Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview
- 5.44 Rhythm Biosciences Ltd Company Overview
- 5.44.1 Rhythm Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.45 Shanghai Singlera Genomics Technologies Co Ltd Company Overview
- 5.45.1 Shanghai Singlera Genomics Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.46 Singlera Genomics Inc Company Overview
- 5.46.1 Singlera Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.47 The Chinese University of Hong Kong Company Overview
- 5.47.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
- 5.48 University of Oxford Company Overview
- 5.48.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
- 5.49 Vastcon Inc Company Overview
- 5.49.1 Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.50 VolitionRX Ltd Company Overview
- 5.50.1 VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Colorectal Cancer Screening Tests- Recent Developments
7 Appendix
List of Tables
List of Tables
- Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
- Colorectal Cancer Screening Tests - Pipeline Products by Segment
- Colorectal Cancer Screening Tests - Pipeline Products by Territory
- Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
- Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
- Colorectal Cancer Screening Tests - Ongoing Clinical Trials
- Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
- Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
- Glossary
List of Figures
List of Figures
- Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
- Colorectal Cancer Screening Tests - Pipeline Products by Segment
- Colorectal Cancer Screening Tests - Pipeline Products by Territory
- Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
- Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
- Colorectal Cancer Screening Tests - Ongoing Clinical Trials
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.